中国癌症杂志 ›› 2014, Vol. 24 ›› Issue (6): 423-432.doi: 10.3969/j.issn.1007-3969.2014.06.005

• 论著 • 上一篇    下一篇

基质金属蛋白酶16在食管鳞癌中的表达及其生物学功能

吴秋丽,林碧芸,吴梦杰,刘明   

  1. 厦门大学附属第一医院消化内科,福建 厦门 361003
  • 出版日期:2014-06-30 发布日期:2014-07-29
  • 通信作者: 刘明 E-mail:xmlming@xmu.edu.cn

Expression and biological role of Matrix metalloproteinases 16 in esophagus squamous cell carcinoma

WU Qiu-li, LIN Bi-yun, WU Meng-jie, LIU Ming   

  1. Department of Digestive System, First Affiliated Hospital to Xiamen University, Xiamen Fujian 361003, China
  • Published:2014-06-30 Online:2014-07-29
  • Contact: LIU Ming E-mail: xmlming@xmu.edu.cn

摘要: 背景与目的:中国是世界上食管癌的高发区,食管癌可发生早期淋巴结及血行转移,这使其表现出临床进展迅速并且预后很差的特性。研究显示癌组织侵袭和转移与其诱导产生的蛋白酶降解细胞外基质、基底膜能力密切相关,因此基质金属蛋白酶(matrix metalloproteinase,MMP)在肿瘤的发生、发展、转移过程中发挥重要作用,本文研究基质金属蛋白酶16(matrix metalloproteinase-16,MMP-16)在食管癌中的表达及其与食管癌浸润转移的关系,并为食管癌早期诊断及靶向治疗提供理论依据。方法:应用免疫组化、蛋白质印迹法(Western blot)及实时定量聚合酶链反应(real-time polymerase chain reaction,RTPCR)检测食管癌及相应的正常组织的MMP-16蛋白表达水平和MMP-16 mRNA转录情况,并对其临床意义进行探讨。通过构建针对MMP-16的小片段发夹状RNA(shRNA)干扰表达质粒,应用划痕实验、Transwell小室实验、WST-1及流式细胞仪检测方法,研究shRNA表达质粒沉默MMP-16后对Eca109细胞的迁移、侵袭、增殖及凋亡水平的影响。采用t检验进行统计学分析。结果:在蛋白水平,MMP-16在癌组织和正常组织表达平均指数分别为0.569±0.380和1.483±0.982,差异有统计学意义(P<0.01)。MMP-16表达与食管鳞癌组织分化程度呈正相关(R=0.704,P<0.05),与肿瘤的分期负相关(P<0.05)。干扰MMP-16的表达后Ec109细胞侵袭及迁移能力明显增加(P<0.05),细胞凋亡水平下降,增殖差异无统计学意义(P>0.05)。结论:MMP-16在食管癌组织中低表达,随着细胞分化程度增加而表达增加,在Eca109细胞中干扰MMP-16后能够抑制肿瘤细胞的迁移、侵袭,并减少凋亡水平,MMP-16在食管癌中可能起保护作用。

关键词: 食管鳞癌, 基质金属蛋白酶16, RNA干扰, 侵袭, 迁移

Abstract:

Background and purpose: Esophageal carcinoma is one of main malignancies with rapid course and a poor prognosis in China. The reasons of poor overall survival are the invasion and metastasis of the tumor. Matrix metalloproteinase (MMPs) play essential roles in promoting tumor invasion and metastasis. In this study, we aimed to investigate the expression and functional significance of matrix metalloproteinase 16(MMP-16) in esophageal squamous cell carcinoma (ESCC). We expect to find a lead molecule for the benefit of early detecting tumor and the development of novel treatment of ESCC. Methods: The expression levels of MMP-16 protein and mRNA in human ESCC and the matched normal tissues were determined by immunohistochemistry, Western blot and Real-Time PCR (RT-PCR). The stable Ec109 cell line with MMP-16 knockdown and negative controls were established by RNA interference technology. The cell migration, invasion, proliferation and cell apoptosis of MMP-16 in stable interfered Ec109 cell line was examined by cell counting, scratch test, Transwell test and flow cytometry assays. The data were analyzed by t test. Results: MMP-16 protein was downregulated in cancerous group compared with the matched normal tissue and correlated with the clinical features of histological differentiation (P<0.05) and tumor stage (P<0.05). The levels of MMP-16 mRNA and protein in Ec109 were significantly decreased by RNA intetrence (P<0.05). We demonstrated that MMP-16 silencing significantly promoted cell invasion and migration (P<0.05), and inhibited cell apoptosis (P<0.05), while no significant effect was observed on cell proliferation (P>0.05). Conclusion: MMP-16 is downregulated in human ESCC tissues. The cell migration and invasion is promoted by interference of MMP-16 in Ec109, while the cell apoptosis is inhibited. MMP-16 may be considered as a target gene for therapy of ESCC.

Key words: Esophageal squamous cell carcinoma, Matrix metalloproteinase-16, RNA interference, Invasion, Migration